evoke study semaglutide Two-year effects of in adults with overweight or obesity: the STEP 5 trial When GLP-1s become brain drugs

Its results are mathematical estimates and should not replace a prescription label, pharmacy instructions, clinical judgment, or guidance from a licensed healthcare provider

Using the data, the researchers simulated seven clinical trials, testing what effect GLP-1s appeared to have on people with existing substance use disorders, as well as whether they appeared to prevent substance use disorders from developing

Research has shown that weight loss triggers compensatory increases in ghrelin (the 'hunger hormone') and reductions in leptin (which signals fullness), creating a biological drive to regain lost weight

Let's take a look at why they exist and how to stop yourself from falling victim to a scam